Condition

Gastroenteropancreatic Neuroendocrine Tumors clinical trials and research

• 2Clinical trials
• 1New in 30 days
• 1Country

All recruiting trials (2)

• Delayed Ga-68 DOTATATE PET/MR for Detecting Liver Metastases in GEP-NETs

  This study tests whether a delayed Ga-68 DOTATATE PET/MR scan can better detect liver metastases in gastroenteropancreatic neuroendocrine tumors compared with the standard Ga-68 DOTATATE PET/CT.

  Recruiting First Affiliated Hospital of Fujian Medical University · Fuzhou, Fujian · NCT07898904

• Albumin‑bound sirolimus plus long‑acting octreotide for metastatic gastroenteropancreatic neuroendocrine tumors

  This test will see if combining albumin‑bound sirolimus with long‑acting octreotide helps people with unresectable or recurrent non‑functional GEP‑NETs who have poor prognostic factors.

  Recruiting Phase 2/3 CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Beijing, Beijing Municipality · NCT07165886

Quick answers

How many Gastroenteropancreatic Neuroendocrine Tumors clinical trials are recruiting right now?

2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →